Evidence map›Paper›PMID 40371020›Full record

ArticleIndian journal of microbiology2025

Microfluidic Systems: Recent Advances in Chronic Disease Diagnosis and Their Therapeutic Management.

Swadha Pandey, Saurabh Gupta, Alok Bharadwaj, Amisha Rastogi

Abstract read
In one paragraph

Article in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. HIV Cure: How Far We Have Come?Indian journal of microbiology · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Swadha Pandey *Department of Biotechnology, GLA University, Mathura, Uttar Pradesh 281406 India.
Saurabh Gupta *Department of Biotechnology, GLA University, Mathura, Uttar Pradesh 281406 India.
Alok BharadwajDepartment of Biotechnology, GLA University, Mathura, Uttar Pradesh 281406 India.ORCID 0000-0002-7383-188X
Amisha RastogiSapien Biosciences, Apollo Health City, Hyderabad, Telangana 500096 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidics has advanced the area of diagnostics during the past ten years by offering fresh approaches that weren't achievable with traditional detection and treatment techniques. High-throughput operations can be carefully controlled by using microfluidics and are very cost-effective too. It has been accepted to be a quick and effective method for controlled medication delivery, biological sample preparation, and analysis. This new technology has made it possible to create a wide range of micro and nanocarriers for poorly soluble medications, which has many advantages over traditional drug delivery techniques. Furthermore, a targeted medication delivery system utilizing microfluidic technology can be developed to enhance the drug's local bioavailability. Over the years, extensive R&D in microfluidic technology has led to the creation of various advanced applications in both laboratory and consumer biotechnology. Miniaturized genetic and proteasome analyzers, cell culture and control platforms, biosensors, disease detection, optical imaging devices, diagnostic advanced drugs, drug delivery schemes, and innovative products are some of the advanced applications of the microfluidics system. Also, these are highly adaptable microfluidic tools for disease detection and organ modeling, as well as transduction devices used in biomedical applications to detect biological and chemical changes. Beyond the specialized difficulties in studying cell-cell interactions, microfluidics has several difficulties in biomedical applications, especially for diagnostic devices where minute interactions can lead to imprecise evaluations. Assay function can be significantly changed by the way plastics, adhesives, and other materials interact. Therefore, the foundation of microfluidic technology needs to be grounded in real-world uses that can be produced on a big scale and at a reasonable cost. Further, it is a very interdisciplinary field that requires the collaboration of professionals in fluidics, assay science, materials science, and instrumentation to provide devices with the proper and needed functionality. In this article, we have discussed the advanced disease diagnosis and their therapeutic management which will help to understand the current scenario in the field of microfluidics diagnosis and will fill knowledge about the 'gap' in the system.

Indexed as

Chronic diseasesDisease diagnosisMicrofluidic systemsTherapeutic aspects

Identifiers

PMID40371020
PMCPMC12069168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.